Clinical Observational Study on the Therapeutic Efficacy of Pirfenidone in Sjögren's Syndrome Complicated with Nonspecific Interstitial Pneumonia.
This study suggests that adding pirfenidone to the treatment regimen for NSIP secondary to Sjögren's syndrome leads to significant improvements in pulmonary function, high-resolution CT scores, and quality of life compared to conventional treatments.
Authors
- Wei Zou (ORCID: https://orcid.org/0000-0001-8292-5127)
- Wei Wei (ORCID: https://orcid.org/0000-0003-4066-0081)
- Jingjing Liu (ORCID: https://orcid.org/0000-0001-7558-5558)
- Wei Han (ORCID: https://orcid.org/0000-0003-0809-5465)
Publication Details
- Journal
- PubMed
- Published
- 2024-09-01
- Citations
- 2
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.84